-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Pharma IT
Anonymous discussion boards for pharma IT employees
-
Actelion IT
- Discussions:
- 2
- Messages:
- 6
-
Amgen IT
- Discussions:
- 24
- Messages:
- 163
-
Baxter IT
- Discussions:
- 4
- Messages:
- 14
-
BiogenIdec IT
- Discussions:
- 1
- Messages:
- 1
-
Bristol Myers Squibb IT
- Discussions:
- 21
- Messages:
- 88
Latest: Inept IT anonymous, Oct 3, 2020 at 10:39 AM -
Elan IT
- Discussions:
- 1
- Messages:
- 1
-
Eli Lilly IT
- Discussions:
- 164
- Messages:
- 1,645
-
Endo IT
- Discussions:
- 1
- Messages:
- 8
-
GE Healthcare IT
- Discussions:
- 3
- Messages:
- 4
-
GlaxoSmithKline IT
- Discussions:
- 8
- Messages:
- 34
-
Hospira IT
- Discussions:
- 1
- Messages:
- 2
-
Jazz Pharmaceuticals IT
- Discussions:
- 1
- Messages:
- 2
-
Johnson & Johnson IT
- Discussions:
- 210
- Messages:
- 3,032
-
Medimmune IT
- Discussions:
- 1
- Messages:
- 6
-
Merck IT
- Discussions:
- 89
- Messages:
- 1,197
-
Pfizer IT
- Discussions:
- 47
- Messages:
- 437
-
Quest Diagnostics IT
- Discussions:
- 1
- Messages:
- 2
-
Sanofi-Aventis IT
- Discussions:
- 13
- Messages:
- 63
-
Schering Plough IT
- Discussions:
- 1
- Messages:
- 3
-
Takeda IT
- Discussions:
- 6
- Messages:
- 41
-
UCB Pharma IT
- Discussions:
- 1
- Messages:
- 1
-
Warner Chilcott IT
- Discussions:
- 1
- Messages:
- 3
-
Wyeth IT
- Discussions:
- 2
- Messages:
- 38